Form 4 for SGHT Sight Sciences, Inc.
Accepted 2025-06-06 00:00:00 ET · period of report 2025-06-04 · accession 0000950170-25-083413 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-06-06 | 2025-06-04+ | SGHT | Encrantz Staffan | Dir, 10% | P - Purchase | $4.22 | +90.5K | 1.32M | +7% | +$381.8K |
| 2025-06-06 | 2025-06-05 | SGHT | Encrantz Staffan | Dir, 10% | A - Grant | $0.00 | +31.0K | 1.35M | +2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-04 | P | A | 21,674 | $4.17 | 1,278,161 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), were purchased in multiple transactions at per share prices ranging from $4.067 to $4.23 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2025-06-06 | P | A | 27,900 | $4.22 | 1,377,964 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. These shares of Common Stock were purchased in multiple transactions at per share prices ranging from $4.20 to $4.245 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. (F5) Includes (i) 1,347,012 shares of Common Stock, and (ii) 30,952 restricted stock units which are subject to vesting as reported herein. |
| 3 | Common | Common Stock | 2025-06-05 | A | A | 30,952 | $0.00 | 1,350,064 | D | — | — | (F3) Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's Non-Employee Director Compensation Program. Each RSU represents a contingent right to receive one share of Common Stock. The number of RSUs granted is equal to approximately $130,000 of shares of Common Stock as determined by the closing price on the grant date, June 5, 2025. The RSUs vest on the earlier of June 5, 2026 and the date of the Issuer's 2026 annual meeting of stockholders, subject to the Reporting Person's continued service as a director on the Company's board of directors through such vesting date. |
| 4 | Common | Common Stock | 2025-06-05 | P | A | 40,951 | $4.24 | 1,319,112 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares of Common Stock were purchased in multiple transactions at per share prices ranging from $4.19 to $4.295 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. |